As for being a home run or not. We know that Leronlimab
As for being a home run or not. We know that Leronlimab works and when and how much in dose size and how often are all things the doctors can justify and prescribe as we go forward once we have a BLA. We just need to show that we work to get a EUA. If we continue to just trial for each different Covid-19 level of disease. It will be a while before we see wide spread use. Who knows... maybe we work best if we dose at Moderate and half the normal rate of SOC/placebo patients continue to Severe and then we dose again and half of those patients don’t go to critical. Then we continue to dose the critical one dose every day until nobody dies. These are possibilities for doctors to try and not left up to trials when we get a BLA. It’s far to slow to continue trials for every covid indication and to many people will die before we get through all the trials possible we can think up for dosing and length of time between.
Good doctors will figure this all out by lab results and being attentive to their occupation as doctors. If our safety continues its golden path and is what we believe it will be going forward. Then Leronlimab could work excellent for Covid. Trials won’t necessarily show all the potential we hope to see. But use in the pandemic will be written about in journals and advertised or spoken about in presentations or even word of mouth social media throughout the medical field.
We just need to get over the hump on the first trial EUA approved before we learn just what Leronlimab can actually do during this early stages of this pandemic. For this, I am excited to see the potential. We are not limited overall by only one or two early trial results. It’s just the beginning of use is all. The door will be opened for more extensive use when we get BLA approval. Then we will all figure out just how good Leronlimab is. This is what I hope will shine through for us all. A drug that works and saves lives. How it is administered or how often we dose it, should be left up to the professionals. Safety will dictate the use of Leronlimab. Let’s hope our safety record holds true. This is the most important aspect going forward as an investor or a patient. As safety allows more of a universal common sense use and ability to change doses and time between doses as doctors dial in the proper use of any drug.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...
Continue Reading
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...
Continue Reading
Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...
Continue Reading
A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...
Continue Reading
Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...
Continue Reading
Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...
Continue Reading
Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...
Continue Reading
A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...
Continue Reading
Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...
Continue Reading
Top 5 Most Recently Viewed Articles
Texas Southern University's College of Education Initiatives Texas Southern University's College of Education (COE), located in the iconic Secretary Roderick R. Paige Building, is embarking on a series of transformative initiatives designed to fortify its leadership role in K–12 education. These initiatives aim to forge stronger partnerships and innovate education...
Continue Reading
Infosys Partners with Metro Bank for Transformation Enables the bank to enhance agility, insight, and employee experience to build a future-ready enterprise BENGALURU, India – Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a frontrunner in next-generation digital services and consulting, has entered into a collaborative agreement with Metro Bank, an independent UK bank,...
Continue Reading
BioAge Labs Expands APJ Agonist Pipeline BioAge Labs, Inc. is making significant strides in the development of therapeutic candidates targeting metabolic diseases, particularly by harnessing the power of the apelin receptor (APJ). This innovative company, based in Emeryville, has recently announced an option agreement with JiKang Therapeutics to potentially in-license a...
Continue Reading
National Press Club Names Outstanding Scholars for 2025 The National Press Club, a pivotal organization dedicated to journalism excellence, has recently announced the winners of its prestigious scholarships for 2025. This initiative aims to acknowledge and support the promising talents of future journalists who are making impactful contributions to their communities. The...
Continue Reading
Yardi Makes Moves with APOLLO Insurance Partnership In a world where rental agreements often feel as thick as a phone book, Yardi's latest shakeup in the Canadian rental market is a breath of fresh air. The company's collaboration with APOLLO Insurance is bringing tenant insurance right into the renters' digital lease experience. This isn't just a neat trick—it's a...
Continue Reading
